Microdilution Technique

Serial twofold dilutions establish a systematic concentration series, with each successive level differing predictably from the previous one. This design makes it possible to examine how increasing or decreasing compound concentration changes a measured biological response. Across the range, researchers can identify concentration-dependent effects and compare responses among compounds under the same testing framework.

MIC and IC50 summarize different features of the measured response. A minimum inhibitory concentration indicates the lowest tested concentration associated with inhibition, whereas a half-maximal inhibitory concentration describes the concentration corresponding to half-maximal inhibition. Interpreting either value requires linking it to the assay readout, such as microbial growth, cell viability, or enzyme activity, and to the tested concentration range.

The biological system added to each well determines what the experiment can reveal. Microorganisms support measurements of growth, cells support viability assessments, and enzymes support activity measurements. Because the same concentration series can be paired with these different readouts, investigators can adapt the assay to antimicrobial susceptibility testing, cellular drug screening, or biochemical pharmacological analysis without changing the central dilution strategy.

A typical workflow begins by preparing the compound across the selected concentration range, often through serial twofold dilution, in microplate wells. Researchers then add the chosen cells, enzymes, or microorganisms, maintain controlled incubation, and measure growth, viability, or activity. Consistent well volumes and concentration assignments help relate the resulting measurements back to the intended dose series.

Microdilution is especially useful when a study must evaluate defined concentration ranges while conserving samples and reagents. In pharmacology, researchers can apply it to antimicrobial susceptibility testing, initial drug screening, and comparative assessment of candidate therapies. The resulting concentration-response patterns help compare compounds that produce stronger or weaker effects across the tested range and support efficient experimental evaluation.

In pharmacology, the technique connects controlled compound exposure with measurable biological outcomes. Concentration-response data can characterize both potency and efficacy, then be summarized with values such as MIC or IC50 when appropriate to the assay. This makes the approach useful for comparing candidate therapies, provided researchers interpret each numerical result alongside the biological readout and experimental concentration range.